185.195.212.179

ip:185.195.212.179

The entity associated with IP address 185.195.212.179 is categorized under the 'Online Pharmacy' sector. It appears to be involved in discussions or reviews related to pharmaceutical products such as Zoloft, which is used for treating depression. The entity's specific offerings or business operations are not clearly detailed in the available data. No ownership or licensing information is provided, making it difficult to ascertain the legitimacy or regulatory compliance of the entity.

ipHigh RiskOnline Pharmacy
Trust Analysis
5
out of 100

Analysis Summary

The digital entity associated with IP address 185.195.212.179, categorized under the 'Online Pharmacy' sector, holds a significantly low trust score of 5/100. This score reflects critical trust concerns, primarily due to a threat report indicating spam activity, which heavily impacts its reputation. While the entity does have valid geolocation data confirming its presence in the US, the absence of a reverse DNS record and a lack of detailed business operations or licensing information raise further questions about its legitimacy and compliance with regulatory standards. The presence of a spam-related threat report is a major red flag, suggesting potential malicious activity and indicating that users should exercise extreme caution. Overall, without clear ownership details and regulatory compliance, the trustworthiness of this entity is highly questionable, and users are advised to approach with significant caution.

Score Breakdown

Entity has 1 threat report(s) with typesSpam
No reverse DNS (PTR) record-10
Valid geolocation data (US)+5
ASN 21769AS-COLOAM
Technical Information
IP Info
Reviews
Anonymous
9/24/2026Spam

The reviews highlight various concerns regarding the use of Zoloft, particularly focusing on its side effects and potential interactions with other substances. Users reported experiencing nausea and fluctuations in blood pressure. Additionally, there were mentions of interactions between Zoloft and substances such as cocaine and marijuana, which may pose significant health risks. These concerns underscore the importance of consulting healthcare professionals when considering Zoloft for depression treatment, especially in the context of existing health conditions or substance use.